
North America Vendor Neutral Archive (VNA) & PACS Market Size, Share & Trends Analysis Report By Product Type, By Vendor Type, By Deployment, By End User, By Application, By Modality, By Country and Growth Forecast, 2024 - 2031
Description
North America Vendor Neutral Archive (VNA) & PACS Market Size, Share & Trends Analysis Report By Product Type, By Vendor Type, By Deployment, By End User, By Application, By Modality, By Country and Growth Forecast, 2024 - 2031
The North America Vendor Neutral Archive (VNA) & PACS Market would witness market growth of 8.6% CAGR during the forecast period (2024-2031).
The US market dominated the North America Vendor Neutral Archive (VNA) & PACS Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $2,228 million by 2031. The Canada market is experiencing a CAGR of 10.7% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 10% during (2024 - 2031).
Vendor neutral archive (VNA) and picture archiving and communication system (PACS) systems facilitate seamless imaging data sharing across different healthcare facility departments. This capability allows for integrated care where specialists from radiology, oncology, cardiology, and other departments can collaborate efficiently using a unified imaging data set. It promotes coordinated patient care by ensuring all healthcare providers can access the most current and comprehensive imaging information.
VNA systems support the creation of longitudinal imaging records, which track a patient's imaging history over time. This feature is particularly valuable for managing chronic conditions and long-term treatments, as it provides a comprehensive view of disease progression or treatment response. It helps monitor changes, assess the effectiveness of interventions, and make informed decisions based on historical imaging data.
As cancer cases rise in Mexico, there will be a greater need for diagnostic imaging services. This increase in demand will drive the adoption of advanced PACS and VNA systems to manage, store, and access high volumes of imaging data efficiently. As per the All. Can, cancer is the third leading cause of death in Mexico. Over 195,000 new cases were registered in 2020. Breast (29.929), prostate (26.742), thyroid (11,227), colon (11,191), and cervical cancer (9,439) were among those with the highest prevalence. With the rise in CVD cases, imaging procedures such as echocardiograms, CT scans, and MRIs will be used more frequently to diagnose and manage these conditions. This will drive demand for VNA and PACS systems capable of efficiently handling large volumes of imaging data. According to the American Heart Association, cardiovascular disease (CVD) remains the leading cause of death in the United States, accounting for 928,741 deaths in 2020. In conclusion, high rates of cancer cases and the increasing burden of CVDs in the region are driving the growth of the market.
Based on Product Type, the market is segmented into VNA (Multi-Department VNA, Department VNA, and Multi-Site VNA) and PACS (Multi-Department PACS, Department PACS, and Multi-Site PACS). Based on Vendor Type, the market is segmented into Independent Vendor and Third-party Vendor. Based on Deployment, the market is segmented into On-Premise, Cloud-Based, and Hybrid Model. Based on End User, the market is segmented into Hospitals & Clinics, Diagnostic Centers, and Others. Based on Application, the market is segmented into Cardiology, Orthopedic, Oncology, Neurology, Obstetrics & Gynecology, and Others. Based on Modality, the market is segmented into Computed Tomography, Mammography, MRI, Ultrasound, X-Rays, and PET. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Hyland Software, Inc.
- GE HealthCare Technologies, Inc.
- Koninklijke Philips N.V.
- Siemens Healthineers AG (Siemens AG)
- Fujifilm Holdings Corporation
- IBM Corporation
- Carestream Health, Inc. (Onex Corporation)
- Novarad Enterprise Healthcare Solutions
- Canon, Inc. (Canon Medical Systems Corporation)
- INFINITT Healthcare Co. Ltd.
By Product Type
- VNA
- Multi-Department VNA
- Department VNA
- Multi-Site VNA
- PACS
- Multi-Department PACS
- Department PACS
- Multi-Site PACS
- Independent Vendor
- Third-party Vendor
- On-Premise
- Cloud-Based
- Hybrid Model
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Cardiology
- Orthopedic
- Oncology
- Neurology
- Obstetrics & Gynecology
- Others
- Computed Tomography
- Mammography
- MRI
- Ultrasound
- X-Rays
- PET
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
191 Pages
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Vendor Neutral Archive (VNA) & PACS Market, by Product Type
- 1.4.2 North America Vendor Neutral Archive (VNA) & PACS Market, by Vendor Type
- 1.4.3 North America Vendor Neutral Archive (VNA) & PACS Market, by Deployment
- 1.4.4 North America Vendor Neutral Archive (VNA) & PACS Market, by End User
- 1.4.5 North America Vendor Neutral Archive (VNA) & PACS Market, by Application
- 1.4.6 North America Vendor Neutral Archive (VNA) & PACS Market, by Modality
- 1.4.7 North America Vendor Neutral Archive (VNA) & PACS Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- Chapter 4. Competition Analysis - Global
- 4.1 KBV Cardinal Matrix
- 4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
- 4.2.3 Acquisition and Mergers
- 4.3 Market Share Analysis, 2023
- 4.4 Top Winning Strategies
- 4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
- 4.4.2 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2020, Aug – 2024, Feb) Leading Players
- 4.5 Porter Five Forces Analysis
- Chapter 5. North America Vendor Neutral Archive (VNA) & PACS Market by Product Type
- 5.1 North America VNA Market by Region
- 5.2 North America Vendor Neutral Archive (VNA) & PACS Market by VNA Type
- 5.2.1 North America Multi-Department VNA Market by Country
- 5.2.2 North America Department VNA Market by Country
- 5.2.3 North America Multi-Site VNA Market by Country
- 5.3 North America PACS Market by Region
- 5.4 North America Vendor Neutral Archive (VNA) & PACS Market by PACS Type
- 5.4.1 North America Multi-Department PACS Market by Country
- 5.4.2 North America Department PACS Market by Country
- 5.4.3 North America Multi-Site PACS Market by Country
- Chapter 6. North America Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
- 6.1 North America Independent Vendor Market by Region
- 6.2 North America Third-party Vendor Market by Region
- Chapter 7. North America Vendor Neutral Archive (VNA) & PACS Market by Deployment
- 7.1 North America On-Premise Market by Country
- 7.2 North America Cloud-Based Market by Country
- 7.3 North America Hybrid Model Market by Country
- Chapter 8. North America Vendor Neutral Archive (VNA) & PACS Market by End User
- 8.1 North America Hospitals & Clinics Market by Country
- 8.2 North America Diagnostic Centers Market by Country
- 8.3 North America Others Market by Country
- Chapter 9. North America Vendor Neutral Archive (VNA) & PACS Market by Application
- 9.1 North America Cardiology Market by Country
- 9.2 North America Orthopedic Market by Country
- 9.3 North America Oncology Market by Country
- 9.4 North America Neurology Market by Country
- 9.5 North America Obstetrics & Gynecology Market by Country
- 9.6 North America Others Market by Country
- Chapter 10. North America Vendor Neutral Archive (VNA) & PACS Market by Modality
- 10.1 North America Computed Tomography Market by Country
- 10.2 North America Mammography Market by Country
- 10.3 North America MRI Market by Country
- 10.4 North America Ultrasound Market by Country
- 10.5 North America X-Rays Market by Country
- 10.6 North America PET Market by Country
- Chapter 11. North America Vendor Neutral Archive (VNA) & PACS Market by Country
- 11.1 US Vendor Neutral Archive (VNA) & PACS Market
- 11.1.1 US Vendor Neutral Archive (VNA) & PACS Market by Product Type
- 11.1.1.1 US Vendor Neutral Archive (VNA) & PACS Market by VNA Type
- 11.1.1.2 US Vendor Neutral Archive (VNA) & PACS Market by PACS Type
- 11.1.2 US Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
- 11.1.3 US Vendor Neutral Archive (VNA) & PACS Market by Deployment
- 11.1.4 US Vendor Neutral Archive (VNA) & PACS Market by End User
- 11.1.5 US Vendor Neutral Archive (VNA) & PACS Market by Application
- 11.1.6 US Vendor Neutral Archive (VNA) & PACS Market by Modality
- 11.2 Canada Vendor Neutral Archive (VNA) & PACS Market
- 11.2.1 Canada Vendor Neutral Archive (VNA) & PACS Market by Product Type
- 11.2.1.1 Canada Vendor Neutral Archive (VNA) & PACS Market by VNA Type
- 11.2.1.2 Canada Vendor Neutral Archive (VNA) & PACS Market by PACS Type
- 11.2.2 Canada Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
- 11.2.3 Canada Vendor Neutral Archive (VNA) & PACS Market by Deployment
- 11.2.4 Canada Vendor Neutral Archive (VNA) & PACS Market by End User
- 11.2.5 Canada Vendor Neutral Archive (VNA) & PACS Market by Application
- 11.2.6 Canada Vendor Neutral Archive (VNA) & PACS Market by Modality
- 11.3 Mexico Vendor Neutral Archive (VNA) & PACS Market
- 11.3.1 Mexico Vendor Neutral Archive (VNA) & PACS Market by Product Type
- 11.3.1.1 Mexico Vendor Neutral Archive (VNA) & PACS Market by VNA Type
- 11.3.1.2 Mexico Vendor Neutral Archive (VNA) & PACS Market by PACS Type
- 11.3.2 Mexico Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
- 11.3.3 Mexico Vendor Neutral Archive (VNA) & PACS Market by Deployment
- 11.3.4 Mexico Vendor Neutral Archive (VNA) & PACS Market by End User
- 11.3.5 Mexico Vendor Neutral Archive (VNA) & PACS Market by Application
- 11.3.6 Mexico Vendor Neutral Archive (VNA) & PACS Market by Modality
- 11.4 Rest of North America Vendor Neutral Archive (VNA) & PACS Market
- 11.4.1 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by Product Type
- 11.4.1.1 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by VNA Type
- 11.4.1.2 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by PACS Type
- 11.4.2 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
- 11.4.3 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by Deployment
- 11.4.4 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by End User
- 11.4.5 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by Application
- 11.4.6 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by Modality
- Chapter 12. Company Profiles
- 12.1 Hyland Software, Inc.
- 12.1.1 Company Overview
- 12.1.2 Recent strategies and developments:
- 12.1.2.1 Partnerships, Collaborations, and Agreements:
- 12.1.2.2 Product Launches and Product Expansions:
- 12.2 GE HealthCare Technologies, Inc.
- 12.2.1 Company Overview
- 12.2.2 Financial Analysis
- 12.2.3 Segmental and Regional Analysis
- 12.2.4 Research & Development Expenses
- 12.2.5 Recent strategies and developments:
- 12.2.5.1 Partnerships, Collaborations, and Agreements:
- 12.2.6 SWOT Analysis
- 12.3 Koninklijke Philips N.V.
- 12.3.1 Company Overview
- 12.3.2 Financial Analysis
- 12.3.3 Segmental and Regional Analysis
- 12.3.4 Research & Development Expense
- 12.3.5 Recent strategies and developments:
- 12.3.5.1 Partnerships, Collaborations, and Agreements:
- 12.3.6 SWOT Analysis
- 12.4 Siemens Healthineers AG (Siemens AG)
- 12.4.1 Company Overview
- 12.4.2 Financial Analysis
- 12.4.3 Segmental and Regional Analysis
- 12.4.4 Research & Development Expense
- 12.4.5 Recent strategies and developments:
- 12.4.5.1 Partnerships, Collaborations, and Agreements:
- 12.4.6 SWOT Analysis
- 12.5 Fujifilm Holdings Corporation
- 12.5.1 Company Overview
- 12.5.2 Financial Analysis
- 12.5.3 Segmental and Regional Analysis
- 12.5.4 Research & Development Expenses
- 12.5.5 Recent strategies and developments:
- 12.5.5.1 Product Launches and Product Expansions:
- 12.5.5.2 Acquisition and Mergers:
- 12.5.6 SWOT Analysis
- 12.6 IBM Corporation
- 12.6.1 Company Overview
- 12.6.2 Financial Analysis
- 12.6.3 Regional & Segmental Analysis
- 12.6.4 Research & Development Expenses
- 12.6.5 Recent strategies and developments:
- 12.6.5.1 Product Launches and Product Expansions:
- 12.6.6 SWOT Analysis
- 12.7 Carestream Health, Inc. (Onex Corporation)
- 12.7.1 Company Overview
- 12.7.2 SWOT Analysis
- 12.8 Novarad Enterprise Healthcare Solutions
- 12.8.1 Company Overview
- 12.8.2 Recent strategies and developments:
- 12.8.2.1 Partnerships, Collaborations, and Agreements:
- 12.8.2.2 Product Launches and Product Expansions:
- 12.8.3 SWOT Analysis
- 12.9 Canon, Inc. (Canon Medical Systems Corporation)
- 12.9.1 Company Overview
- 12.9.2 Financial Analysis
- 12.9.3 Segmental and Regional Analysis
- 12.9.4 Research & Development Expenses
- 12.9.5 Recent strategies and developments:
- 12.9.5.1 Partnerships, Collaborations, and Agreements:
- 12.9.5.2 Product Launches and Product Expansions:
- 12.9.6 SWOT Analysis
- 12.10. INFINITT Healthcare Co. Ltd.
- 12.10.1 Company Overview
- 12.10.2 Recent strategies and developments:
- 12.10.2.1 Partnerships, Collaborations, and Agreements:
- 12.10.2.2 Product Launches and Product Expansions:
- 12.10.3 SWOT Analysis
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.